drugset / Trial / NCT01616485
Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of this study is to evaluate the hemodynamic response to a sublingual dose of glyceryl trinitrate in subjects receiving oral TA-1790, sildenafil citrate, and placebo.
Timeline
- Start
- 2004-03
- Primary completion
- 2004-05
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avanafil | Small molecule | 200 mg | Oral |
| Subject | Nitroglycerin | Unknown | 0.4 mg | Subcutaneous |
| Comparator | Sildenafil | Unknown | 100 mg | Oral |